A Phase III, Multi-centre, Randomized Study to Compare the Efficacy and Safety of Levonadifloxacin (IV and Oral) With Linezolid (IV and Oral) in Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
Phase of Trial: Phase III
Latest Information Update: 06 Aug 2019
Price : $35 *
At a glance
- Drugs Alalevonadifloxacin (Primary) ; Levonadifloxacin (Primary) ; Linezolid; Linezolid
- Indications Bacterial infections; Skin infections
- Focus Registrational; Therapeutic Use
- Sponsors Wockhardt
- 02 Aug 2019 Status changed from active, no longer recruiting to completed.
- 12 Nov 2018 Status changed from recruiting to active, no longer recruiting.
- 30 Aug 2018 Planned primary completion date changed from 1 Jul 2018 to 25 Sep 2018.